SCHEMBL19757723

SCHEMBL19757723

C[SiH](C)c1ccc([Si](C)(C)C)cc1-c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.34
▸ TDO2 P48775 2/20 0.33
▸ PIN1 Q13526 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ ESR2 Q92731 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ AKT1 P31749 1/20 0.32
▸ AKT2 P31751 1/20 0.32
▸ SMARCA2 P51531 1/20 0.32
▸ SMARCA4 P51532 1/20 0.32
▸ PBRM1 Q86U86 1/20 0.32
▸ ENPP3 O14638 1/20 0.31
▸ ENPP1 P22413 1/20 0.31
▸ NUDT1 P36639 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ SQOR Q9Y6N5 1/20 0.31
▸ PSMB5 P28074 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ ESR1 P03372 1/20 0.31
▸ PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16852486 0.77 RAB9A (0.42) BACE1ESR2AKT1AKT2ENPP3
SCHEMBL15453485 0.77 PTGS2 (0.37) BACE1TDO2ESR2AKT1AKT2
SCHEMBL19757724 0.76 GABRA1 (0.42) ESR2MAPTNPC1RAB9AKDM4E
SCHEMBL28310672 0.76 ALDH1A1 (0.48) BACE1TDO2SMARCA2SMARCA4PBRM1
SCHEMBL16562891 0.73 ALDH1A1 (0.42) BACE1ESR2TDP1AKT1AKT2
SCHEMBL29776868 0.73 ALDH1A1 (0.42) BACE1ESR2TDP1AKT1AKT2
SCHEMBL20180021 0.72 SQOR (0.46) BACE1TDO2ESR2AKT1AKT2
SCHEMBL13995119 0.71 GPR84 (0.38) BACE1TDO2ESR2TDP1ENPP1
SCHEMBL31367772 0.71 L3MBTL1 (0.46) TDP1PTGS2MAPTNPC1RAB9A
SCHEMBL30679836 0.69 PTGER4 (0.38) TDP1PTGS2MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180006225-A1 Compositions with Triarylamine Derivatives and Oled Device Containing the Same DOW GLOBAL TECHNOLOGIES LLC 2018-01-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180006225-A1 Compositions with Triarylamine Derivatives and Oled Device Containing the Same DRD2, NSD2, DRD4 BACE1 1322/4885TDO2 75/4885PIN1 3218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback